Carlsbad, CA, United States of America

Kenneth Walter Locke

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Medicinova, Inc., Neothetics, Inc., Lithera, Inc. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Walter Locke. Retrieved from https://idiyas.com/inventor/kenneth-walter-locke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 78.9

 

 

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 80(Granted Patents)


Location History:

  • Gainesville, TX (US) (2023)
  • Carlsbad, CA (US) (2006 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Kenneth Walter Locke: Innovative Contributions and Patents

Introduction:

Kenneth Walter Locke, a seasoned inventor hailing from Carlsbad, CA, has left a remarkable imprint in the field of innovations and patents. With a total of 17 patents to his name, Locke's contributions have greatly impacted the treatment of progressive neurodegenerative diseases and cosmetic procedures for adiposity reduction. This article aims to explore some of his latest patents, illustrious career highlights, notable collaborations, and the overall significance of his work.

Latest Patents:

Locke's recent patents reflect his dedication to advancing medical treatments. One of his latest patents is focused on the treatment of progressive neurodegenerative diseases using ibudilast. This composition and method involve administering ibudilast, a compound known as 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine, to alleviate the symptoms associated with such conditions.

Additionally, Locke's inventive prowess extends to the field of cosmetic treatments. He has developed selective, lipophilic, and long-acting beta agonist monotherapeutic formulations. These formulations are designed to target adiposity and contour bulging, offering innovative approaches to body contour defects like abdominal bulging. Through injectable formulations, the active ingredients, consisting of lipophilic long-acting selective beta-2 adrenergic receptor agonists, provide effective treatment options.

Career Highlights:

Throughout his career, Locke has been associated with esteemed companies, further evidencing his impact in the industry. Notably, Locke has contributed to the progress of Medicinova, Inc., a prominent pharmaceutical company. Medicinova, Inc. has consistently focused on the development of innovative treatments for various diseases, benefitting from Locke's expertise.

Another noteworthy company Locke has collaborated with is Neothetics, Inc., a leading provider of non-invasive aesthetic procedures. Neothetics, Inc. specializes in developing innovative solutions for body contouring and aesthetic treatments. Locke's contributions to such companies have undoubtedly played a significant role in advancing their respective fields.

Collaborations:

Locke's accomplishments have often been accompanied by collaborations with esteemed individuals. Among his notable coworkers is Michael E. Kalafer, who has also made a name for himself in the field of inventions and patents. Their collaborative efforts showcase the synergistic exchange of ideas and innovative spirit that drives progress in these domains. Additionally, Locke has worked alongside Kazuko Matsuda, another respected figure in the industry, amplifying their collective impact on advancements in neurodegenerative disease treatments and cosmetic treatments.

Conclusion:

Innovator extraordinaire Kenneth Walter Locke has demonstrated his tremendous dedication to improving medical treatments and cosmetic procedures. His latest patents highlight his commitment to advancing the treatment of progressive neurodegenerative diseases and innovative approaches to body contouring. Collaborations with renowned companies such as Medicinova, Inc. and Neothetics, Inc., as well as esteemed colleagues like Michael E. Kalafer and Kazuko Matsuda, further solidify Locke's contributions to the field of innovations and patents. Thanks to inventors like Kenneth Walter Locke, the world continues to witness remarkable advancements in healthcare and aesthetics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…